Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?

Nature Clinical Practice. Urology
Susan F Slovin

Abstract

Neuroendocrine differentiation of the prostate is often associated with a dismal prognosis. Whilst it is relatively rare compared with other forms of prostate cancer, it nevertheless remains difficult to treat these cancers effectively and to maintain a durable response. Research aimed at understanding the complexity of neuroendocrine differentiation of the prostate has been conducted for some time. The cells involved in this process secrete a variety of factors that can influence growth patterns and regulatory pathways. Many of these factors can be monitored serologically, but the relationship between the biology of the tumor and clinical response is often discordant. This review outlines the difficulties in treating this disease, both at the time of diagnosis and in the metastatic setting, and focuses on an area of research that remains challenging to both the researcher and clinician.

References

Mar 1, 1992·The Journal of Urology·R J AmatoF H Dexeus
Jul 1, 1991·The Journal of Clinical Endocrinology and Metabolism·D Wynick, S R Bloom
Apr 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K KellyS D Fossa
Dec 1, 1994·The American Journal of Surgical Pathology·D G BostwickP C Wollan
Mar 4, 1998·Journal of Clinical Laboratory Analysis·J T WuR A Stephenson
Jul 2, 1999·Virchows Archiv : an International Journal of Pathology·B Helpap, J Köllermann
Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A di Sant'Agnese
Jul 4, 2002·Annals of the New York Academy of Sciences·Giovanni Muzzonigro, Andrea B Galosi
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christos N PapandreouChristopher J Logothetis
May 22, 2004·Annals of the New York Academy of Sciences·Anders SundinHåkan Orlefors
Oct 30, 2004·Scandinavian Journal of Gastroenterology·U SyversenH L Waldum
Nov 17, 2004·The American Journal of the Medical Sciences·Prasanna Kumar VenkateshLawrence Feldman
Jan 22, 2005·European Urology·Nadezda Vashchenko, Per-Anders Abrahamsson
Jan 25, 2005·Critical Reviews in Eukaryotic Gene Expression·George P Amorino, Sarah J Parsons

❮ Previous
Next ❯

Citations

Mar 19, 2013·Asian Journal of Andrology·Zhen LiJiaoti Huang
Jun 21, 2008·World Journal of Surgical Oncology·Yiyan Liu
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles J RyanEric J Small
Oct 29, 2010·Journal of Biomedicine & Biotechnology·Abhinav SidanaRonald Rodriguez
Nov 21, 2009·Urologic Oncology·Nishtman DizeyiPer-Anders Abrahamsson
Aug 5, 2008·Current Opinion in Pharmacology·Yu ChenHoward I Scher
Jun 2, 2007·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Ildefonso IngelmoLuis Santamaría
Nov 26, 2011·Bioscience Reports·Gina M Bernardo, Ruth A Keri
May 22, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Kazuyoshi KataokaNobuhisa Ishii
Nov 21, 2007·Urologia Internationalis·Luca CindoloAlexandre de la Taille
Jun 10, 2009·International Journal of Cancer. Journal International Du Cancer·Isabel QuirósJuan C Mayo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.